Borregaard ASA: EBITDA1 of NOK 511 million in the 1st quarter

30 Apr 2025 07:00 CEST

Borregaard's operating revenues increased to NOK 2,036 million (NOK 1,975
million)(2) in the 1(st) quarter of 2025. EBITDA(1) reached NOK 511 million (NOK
442 million). The result in BioSolutions increased, BioMaterials had a result in
line with the corresponding quarter last year and Fine Chemicals had a lower
result.

Strong sales to agriculture were the main reason for the all-time high result in
BioSolutions. For BioMaterials, higher sales prices were offset by lower sales
volume, increased wood costs, and cost increases in general. Lower sales prices
for bioethanol were the main reason for the weaker result in Fine Chemicals. The
net currency effects were positive.

Profit before tax was NOK 319 million (NOK 261 million). Earnings per share were
NOK 2.52 (NOK 2.01).

- We are pleased to report an all-time high result for BioSolutions. Our
specialisation strategy has demonstrated resilience amid challenging
macroeconomic conditions and will remain the key driver of our future success,
says President and CEO Per A. Sørlie.

Contacts:
Director Investor Relations, Knut-Harald Bakke, +47 905 79 164
Director Communications, Tone Horvei Bredal, +47 924 67 711

1. Operating profit before depreciation, amortisation and other income and
expenses
2. Figures in parentheses are for the corresponding period in the preceding year

This information is considered to be inside information pursuant to the EU
Market Abuse Regulation and is subject to the disclosure requirements pursuant
to Section 5 - 12 of the Norwegian Securities Trading Act.

This stock exchange announcement was published by Lotte Kvinlaug, Investor
Relations Officer at Borregaard ASA, on 30 April 2025 at 07:00 CEST.

More information:
Access the news on Oslo Bors NewsWeb site

644813_Quarterly and accounting figures 1st quarter 2025.pdf
644813_1st quarter 2025 report.pdf
644813_1st quarter 2025 presentation.pdf